强痛定治疗介入治疗术中疼痛的临床观察  

Clinical observation of bucinperazine for severe pain during interventional therapy

作　　者：陈昕[1] 邓洪梅[1] 张纪良[2] 贾钰铭[1] 

机构地区：[1]宜宾市第二人民医院,四川宜宾644000 [2]成都市第七人民医院,四川成都610021

出　　处：《基层医学论坛》2009年第10期311-312,共2页The Medical Forum

摘　　要：目的探讨用强痛定治疗恶性肿瘤介入治疗术中中重度疼痛的止痛作用及安全性。方法采用自身对照研究的方法,将在介入治疗术中出现中重度疼痛的恶性肿瘤患者进行VAS评分,VAS≥4分的患者,先予以阿托品0.5mg静脉注射,10min后如无效予以强痛定治疗,起始剂量为100mg,10min后据疼痛程度调整是否继续予以强痛定治疗。结果阿托品的疼痛缓解率为11.11%,强痛定的疼痛缓解率为83.33。%不良反应主要表现为头昏、呕吐等,经对症治疗后可明显改善,未出现对强痛定成瘾及其他严重的不良反应。结论强痛定对恶性肿瘤介入治疗术中的疼痛有较好的止痛效果,且较迅速、安全,为介入治疗术中的疼痛提供了一个好的止痛方法。Objective To study bucinperazine＇ s ability of relieving the severe pain during interventional therapy for malignant tumor. Methods Own control study was used. Patients with the severe pain during interventional therapy were graded by VAS .The patients （ VAS ≥4 ） were treated with atropine （ 0.5 mg） firstly. If the pain hadn＇t got easier Bueinperazin were used.The initial dose wasl00 mg .If the pain was not relieved, Bucinperazin would be administered again.Results The rate of relief of atropine was 11.11%.The rate of relief of atropine was 83.33%. The adverse effect were dizzy, heave et al. All the adverse effect were controlled after treatment and no addiction was found.Conclusion The severe pain during interventional therapy for patients with malignant tumor can be effectively and safely controlled with bucinperazine.

关 键 词：强痛定 恶性肿瘤 介入治疗 疼痛 

分 类 号：R730.5[医药卫生—肿瘤]